Host: Carol Wysham, MD

From newly approved treatments to emerging clinical trial data, Dr. Carol Wysham shares some of the highlights from the American Diabetes Association’s 82nd Scientific Sessions, exploring developments in GLP-1 receptor agonists, barriers to patient use, and more.